Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Biomarkers for diagnosing non-alcoholic steatohepatitis (NASH) or hepatocellular carcinoma (HCC)

Biomarkers for diagnosing non-alcoholic steatohepatitis (NASH) or hepatocellular carcinoma (HCC)

US Patent 11774459 · Granted Oct 3, 2023

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Biomarkers for diagnosing non-alcoholic steatohepatitis (NASH) or hepatocellular2025
Biomarkers for diagnosing non-alcoholic steatohepatitis (NASH) or hepatocellular2025
Cloud router platform for SDN networks2023
Cloud-based service policy reroute2022
Managing software changes to virtual network functions2020
Operational micro-services design, development, deployment2020